Northwest Biotherapeutics

Northwest Biotherapeutics (NWBT) is a biotechnology company focused on the clinical development of autologous immunotherapy products for cancer. Our technology platform, DCVax®, uses a patient’s own dendritic cells, the starter engine of the immune system, which are loaded with tumor proteins or antigens. Injection of these cells back into the patient initiates a potent immune response against cancer cells, resulting in delayed time to progression and prolonged survival. Our two lead product candidates, DCVax®-Prostate and DCVax®-Brain are entering FDA-allowed late stage clinical trials from which licensure is possible. Other, related products in our pipeline are ready to enter Phase I clinical trials. The advantage of our DCVax® platform is derived from: the high quality and purity of our DCVax® product candidates; our unique therapeutic approach in which immunotherapy is positioned as an adjuvant treatment in patients with low tumor burden; our proprietary, efficient, and low cost method of product manufacturing.

Contact Details: 18701 120TH AVENUE NE, SUITE 101 Bothell Washington 98011 United States of America Tel: 425-608-3000 Fax: Email: info@nwbio.com WWW: www.nwbio.com/

Loading...

BioNews Results for Northwest Biotherapeutics:
Northwest Secures US$1.0 Million Debt Financing	KRON4:  Oct 2 2008 8:35AM Matching: northwest biotherapeutics
Northwest Secures US$1.0 Million Debt Financing	Montana's News Station:  Oct 2 2008 7:29AM Matching: northwest biotherapeutics
Northwest Secures US$1.0 Million Debt Financing	KLFY:  Oct 2 2008 6:50AM Matching: northwest biotherapeutics
Northwest Secures US$1.0 Million Debt Financing	Genetic Engineering News:  Oct 2 2008 6:34AM Matching: northwest biotherapeutics
Northwest Secures US$1.0 Million Debt Financing	Yahoo!:  Oct 2 2008 6:24AM Matching: northwest biotherapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Northwest Biotherapeutics news.

Northwest Biotherapeutics Patents:
US Patent No.	Title
7087715	Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses
6936448	Nucleic acids and proteins of a rat ganglioside GM1-specific .alpha.1-2fucosyltransferase and uses thereof
6863887	Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
6150508	Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
5990294	Nucleotide and amino acid sequences of C4-2, a tumor suppressor gene, and methods of use thereof
→View more Northwest Biotherapeutics patents.

Northwest Biotherapeutics (NWBT.OB) Financial information Links from Barchart
NWBT.OB Quote from from Barchart.com
NWBT.OB Chart from from Barchart.com
NWBT.OB Profile from from Barchart.com
NWBT.OB Opinion from from Barchart.com
→View more Northwest Biotherapeutics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 169 times since April 2007, the link to the organisation's website has been followed 51 times

Recent Search Terms used to find this page: info@nwbio.com | .

Search for more companies in Bothell

Search for more companies in Washington

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Northwest Biotherapeutics